HomeCompareHFCVX vs JNJ

HFCVX vs JNJ: Dividend Comparison 2026

HFCVX yields 6.83% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HFCVX wins by $11.4K in total portfolio value
10 years
HFCVX
HFCVX
● Live price
6.83%
Share price
$24.12
Annual div
$1.65
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.4K
Annual income
$1,053.64
Full HFCVX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — HFCVX vs JNJ

📍 HFCVX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHFCVXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HFCVX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HFCVX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HFCVX
Annual income on $10K today (after 15% tax)
$580.34/yr
After 10yr DRIP, annual income (after tax)
$895.59/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, HFCVX beats the other by $191.98/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HFCVX + JNJ for your $10,000?

HFCVX: 50%JNJ: 50%
100% JNJ50/50100% HFCVX
Portfolio after 10yr
$25.7K
Annual income
$940.71/yr
Blended yield
3.66%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

HFCVX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HFCVX buys
0
JNJ buys
0
No recent congressional trades found for HFCVX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHFCVXJNJ
Forward yield6.83%3.36%
Annual dividend / share$1.65$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$31.4K$20.0K
Annual income after 10y$1,053.64$827.78
Total dividends collected$8.7K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HFCVX vs JNJ ($10,000, DRIP)

YearHFCVX PortfolioHFCVX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,383$682.75$10,676$355.77+$707.00HFCVX
2$12,906$726.31$11,407$389.39+$1.5KHFCVX
3$14,579$769.63$12,198$426.53+$2.4KHFCVX
4$16,412$812.52$13,056$467.62+$3.4KHFCVX
5$18,416$854.84$13,987$513.12+$4.4KHFCVX
6$20,601$896.45$14,998$563.56+$5.6KHFCVX
7$22,980$937.24$16,098$619.52+$6.9KHFCVX
8$25,566$977.09$17,295$681.69+$8.3KHFCVX
9$28,372$1,015.91$18,599$750.82+$9.8KHFCVX
10$31,411$1,053.64$20,022$827.78+$11.4KHFCVX

HFCVX vs JNJ: Complete Analysis 2026

HFCVXStock

The fund invests in larger, dividend-paying common stocks by utilizing a quantitative formula known as the Cornerstone Value Strategy (the "Value Strategy"). It purchases 50 stocks weighted equally by dollar amount, with 2% of the portfolio's assets invested in each. Using the Value Strategy, the universe of stocks is re-screened and the portfolio is rebalanced annually, generally in the winter.

Full HFCVX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this HFCVX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HFCVX vs SCHDHFCVX vs JEPIHFCVX vs OHFCVX vs KOHFCVX vs MAINHFCVX vs ABBVHFCVX vs MRKHFCVX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.